Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
3019	<b>The People's CSO</b> By Edyta Zielinska the-scientist.com	idos	-	3/10/2008
3018	Sustained complete remissions in multiple myeloma linked to bortezomib in total	Icebrg	-	2/29/2008
3017	Combined pegylated liposomal doxorubicin and bortezomib is highly effective in p	Icebrg	-	2/28/2008
3016	>>MORGAN STANLEY DOWNS MLNM..AS OVERVALUED! 21-Dec-07 09:17 am >> [	Icebrg	-	2/25/2008
3015	[Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances th	tuck	-	2/24/2008
3014	Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin&	Icebrg	-	2/20/2008
3013	Phase II study of bortezomib in patients with previously treated advanced urothe	Icebrg	-	2/16/2008
3012	Scientists Find New Receptor for H.I.V. By LAWRENCE K. ALTMAN Published: Februa	Icebrg	-	2/12/2008
3011	Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cel	Icebrg	-	2/7/2008
3010	Cephalon throws its hat in the next generation proteasome inhibitor ring: >&	tuck	-	2/6/2008
3009	The recent Wachovia presentation is well worth listening to. It is for once neit	Icebrg	-	2/2/2008
3008	Priority review for front line MM +++++++++++++++++ Millennium:FDA OKs Priorit	Ian@SI	-	1/30/2008
3007	Here's the JCI editorial on the bone building aspect of Bortezomib, with a l	tuck	-	1/28/2008
3006	Bortezomib-induced skin eruption. Dermatology. 2008;216(2):156-8. Epub 2008 Jan	Icebrg	-	1/26/2008
3005	Cancer treatment may also help osteoporosis Fri Jan 25, 2008 10:40pm GMT WASHIN	Icebrg	-	1/26/2008
3004	[Efficacy and safety of bortezomib in patients with renal impairment: results fr	tuck	-	1/21/2008
3003	The company said it expects to complete enrollment in an ongoing Phase II trial	Icebrg	-	1/19/2008
3002	FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Dise	Icebrg	-	1/14/2008
3001	Revlimid one Q sale is like Velcade whole year. biz.yahoo.com Three years ago	Miljenko Zuanic	-	1/7/2008
3000	Tandutinib, an oral, small-molecule inhibitor of FLT3 for the treatment of AML a	Icebrg	-	1/6/2008
2999	Millennium Pharmaceuticals "outperform" Thursday, January 03, 2008 7:	Icebrg	-	1/4/2008
2998	The proteasome inhibitor bortezomib in combination with gemcitabine and carbopla	Icebrg	-	1/3/2008
2997	Bortezomib blocks Bax degradation in malignant B-cells during treatment with TRA	Icebrg	-	12/28/2007
2996	Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Thr	Icebrg	-	12/28/2007
2995	Millennium Pharmaceuticals "outperform" Wednesday, December 26, 2007	Icebrg	-	12/26/2007

Go to reply# or date (mm/dd/yy):